Foghorn Therapeutics Inc. Common Stock Stock Prediction
AI-powered sentiment analysis and prediction trends for FHTX, updated each market day.
FHTX AI Sentiment
AI predicts Foghorn Therapeutics Inc. Common Stock stock is likely to increase over the next 10 market days.
Prediction date: April 10, 2026
Subscribers see precise scores, buy/sell targets, and full analytics.
About Foghorn Therapeutics Inc. Common Stock
Foghorn Therapeutics Inc is a clinical stage, precision therapeutics biotechnology company focused on pioneering a new class of medicines that treat serious diseases by correcting abnormal gene expression through selectively targeting the chromatin regulatory system. Its proprietary platform is designed to provide an integrated, mechanistic understanding of interactions within the chromatin regulatory system, supporting the identification and validation of potential therapeutic targets. The company's flagship program is FHD-909.
Sector
Exchange
Market Cap
$281,174,178
Cap Tier
Employees
106
Headquarters
CAMBRIDGE, MA
Listed Since
Oct. 23, 2020
Website
FHTX Sentiment Trend — Last 30 Predictions
Sentiment zones: Bullish · Neutral · Bearish
FHTX Volatility
Foghorn Therapeutics Inc. Common Stock has shown high price volatility over the last 5 trading days. High volatility means larger price swings — this can present both opportunity and risk for traders.
